Pharmafile Logo
Pharmafocus logo
Advanced Search

Oklahoma

Showing 4 posts of 4 posts found.

J&J must pay $572 million for fuelling opioid crisis in Oklahoma, judge says

August 27, 2019
Manufacturing and Production J&J, JJ, Johnson & Johnson, Oklahoma, opioid crisis, opioids, pharma

A judge in Oklahoma has said that Johnson & Johnson must pay $572 million for the part it played in …

News

Oklahoma lawyers say J&J is kingpin of pharmaceutical cartel

July 16, 2019
Manufacturing and Production J&J, JJ, Oklahoma, opioid crisis, opioids, pharma

Lawyers representing the State of Oklahoma described Johnson & Johnson as the ‘kingpin’ in a ‘pharmaceutical cartel’ as they accused …

News

J&J ‘worse’ than Purdue Pharma expert witness says

June 12, 2019
Research and Development J&J, JJ, Johnson & Johnson, Oklahoma, opioid crisis, phamra

The role Johnson & Johnson played in the opioid crisis was ‘in some ways worse’ than that of Purdue Pharma, …

News
920x920

Purdue Pharma settle Oklahoma lawsuit for $270 million

March 26, 2019
Research and Development Oklahoma, OxyContin, Purdue Pharma, opioid crisis, oxycodone

OxyContin drugmaker Purdue Pharma has agreed to pay nearly $270 million to the state of Oklahoma, in order to settle …

News

Latest content

Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement

April 25, 2024

Ascendis Pharma’s Yorvipath approved by MHRA for hypoparathyroidism treatment

April 25, 2024

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024